We can't find the internet
Attempting to reconnect
13750.1;12 PFFLE-LS
Antibody-based therapy for type-2 diabetes
Zusammenfassung
Antibody-based therapy for type-2 diabetes
Weitere Texte
Abstract
The project focuses on the development of an immunotherapy targeting toxic aggregates of islet amyloid polypeptide which are associated with the loss of pancreatic beta-cells in type-2 diabetes patients. Combining Neurimmune¿s expertise in the discovery and validation of human antibodies and academic partners' know-how in diabetes and amyloidosis research, the joint program is aimed at providing in vivo proof-ofconcept for this novel therapeutic strategy for type-2 diabetes.
Beteiligte
Roger Nitsch
Kontaktperson
nitsch@bli.uzh.ch
Universität Zürich Roger Nitsch August-Forel-Strasse 1 Abteilung f. Psychiatrische Forschu 8008 Zürich ZH CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2012-02-29
- Enddatum
- 2015-11-10
- Bewilligte Gesamtkosten
- CHF 900000.00
- Sektion
- 5 KTI
- NABS Politikbereich
- Nicht aufteilbare / nicht zuteilbare Forschung
Forschungsdisziplinen
- T490 Biotechnology 100.0%